[Immunity indices in patients with cancer of the uterine body treated with 17-alpha-oxyprogesterone-capronate].
Based on the findings in 163 endometrial cancer patients, it is shown that following their treatment with 17-alpha-oxyprogesterone-capronate (17-OPC) there occur differential changes in some indices of the cell and humoral immunity: less frequent positive results of delayed hypersensitivity reaction (DHR) with the tumor-associated antigen and more frequent ones with tuberculin; less number of positive responses of the Hougne microprecipitation reaction with tumor-associated and embryonal antigens. Simultaneously, the same patients show a reduced functional activity of immune lymphocytes -- RBT and RSFSR.